Doxycycline Hyclate Tablet, Film Coated
Product Images NDC 62332-387

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Doxycycline Hyclate (NDC 62332-387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxycycline 150 mg

Label for Doxycycline Hyclate Tablets USP 150 mg, film-coated oral tablets, with a count of 60 tablets per package. The label shows the NDC number 62332-388-60 and identifies Alembic Pharmaceuticals Inc. as the labeler. It includes storage instructions and a barcode, with warnings to keep the medication out of reach of children.*

FDA Label Image

150 mg Treatment (Doxycycline 150)

The image shows an oval-shaped film-coated tablet imprinted with 'L | 2 3'. This tablet is identified as doxycycline hyclate. The imprint aids in tablet identification for the 150 mg or 75 mg strengths manufactured by Alembic Pharmaceuticals Inc.*

FDA Label Image

Doxycycline 75 mg

Label for Doxycycline Hyclate Tablets USP, 75 mg strength, oral film-coated tablets. The label states 60 tablets per container and includes storage instructions. It is manufactured by Alembic Pharmaceuticals Inc., with manufacturing locations in India and USA. The label features barcodes, dosage details, and the Alembic logo.*

FDA Label Image

Full Tablet Side View (Doxycycline Fulltabview 2)

An instructional line drawing depicting two hands holding a film-coated tablet, demonstrating how to break or split the tablet in half by applying pressure with the thumbs.*

FDA Label Image

Full Tablet Side View (Doxycycline Fulltabview)

DOXYCYCLINE HYCLATE 150 mg film-coated tablets are presented in a silver and white blister pack with individual tablet compartments. The packaging includes black printed text for product identification and blister grid layout. The labeler Alembic Pharmaceuticals Inc. is associated with this oral prescription drug.*

FDA Label Image

One-third Tablet Side View (Doxycycline Onethirdtabletsideview 50)

An instructional line drawing showing a hand holding a small tablet between the thumb and index finger, demonstrating the tablet size or how to hold it.*

FDA Label Image

One-third Tablet Side View (Doxycycline Onethirdtabletsideview50)

DOXYCYCLINE HYCLATE 150 mg film-coated tablets, depicted as a black and white line drawing of a single oval tablet with a scored line across the center. The image highlights the tablet shape and scoring without any additional text or markings visible.*

FDA Label Image

One-third Tablet Top View (Doxycycline Onethirdtablettopview50)

FDA Label Image

Structure (Doxycycline Structure)

Chemical structure of doxycycline hyclate, showing its core tetracycline ring system with attached hydrochloride (HCl), ethanol (C2H5OH), and water (H2O) molecules as part of the hyclate salt form.*

FDA Label Image

Two-thirds Tablet Side View (Doxycycline Twothirdstabletsideview)

An illustration of a film-coated tablet with a specific shape featuring beveled edges and a scored line across its center for splitting. The tablet design allows for oral administration and corresponds to a doxycycline hyclate product.*

FDA Label Image

Two-thirds Tablet Side View (Doxycycline Twothirdstabletsideview100)

An instructional line drawing showing two hands holding and separating a film-coated tablet, illustrating how to break the tablet.*

FDA Label Image

Two-thirds Tablet Top View (Doxycycline Twothirdstablettopview)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.